Centene Corp. (CNC) Cash Flow Statement

The dramatic swing from -$978M in Q3 2024 to $4.4B in Q2 2026 indicates that premium cash inflows are now outpacing claim outflows, likely driven by improved underwriting discipline and favorable reserve development. However, the volatility in OCF/NI ratio—ranging from -7.06 to 4.01—suggests that cash generation is not yet stable, and investors should monitor whether this rebound is sustainable or a one-time catch-up.

The decline in claims paid from $45.8B to $39.8B year-over-year aligns with the improved combined ratio of 96.9% in Q2 2026, indicating that medical cost inflation may be decelerating. However, the absolute level of claims remains high, and any resurgence in utilization could quickly reverse the margin recovery. The stability in claims payments over the last two quarters suggests a potential plateau, but the sustainability of this trend is uncertain given the ongoing Medicaid redeterminations.

The pattern of net investment sales across all quarters—ranging from $0.4B to $1.4B—suggests that Centene is relying on its investment portfolio as a source of liquidity, possibly to cover operational shortfalls or to fund strategic initiatives. While this provides short-term flexibility, it may also signal that core cash generation is insufficient to meet all cash needs, which could be a concern if the trend persists. The $17.9B cash pile provides a cushion, but continued liquidation could erode investment income potential.

The high OCF/NI ratio indicates that reported earnings are being supplemented by non-cash items such as depreciation, amortization, or reserve releases. While this is common in insurance, the magnitude—especially in quarters with negative net income—implies that cash generation is more robust than earnings suggest. However, investors should be cautious: if the gap narrows, it could indicate that earnings quality is deteriorating. The negative OCF/NI ratios in 2024 and 2025 highlight the volatility, and the recent improvement may be partly due to timing of premium collections and claim payments.

The near-zero buybacks and zero dividends indicate that Centene is not returning capital to shareholders, likely due to its focus on deleveraging and funding its Value Creation Plan. This conservative approach may be prudent given the recent margin pressures, but it also means shareholders are not being rewarded directly. The lack of capital return, combined with net investment sales, suggests that cash is being retained for operational needs and debt service, which could limit upside for investors seeking income or buyback-driven EPS growth.